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Background The Chain of hope acts since 1988 to free operate African,
Asian and Middle East children with heart diseases. This study aimed to
assess the feasibility and results of a 10-year open-heart surgery program at
the Maputo Heart Institute, Mozambique.
Methods and results Data of all consecutive patients with history of at least one
heart surgery performed at the Maputo Heart Institute between Jan. 2001 and Dec.
2011 were opening were analyzed, in regard peri-operative (in-hospital) as well as
long-term follow-up. Overall, 891 operations were performed in 776 patients,
including 93% performed exclusively by one of the 7 international teams and 7%
by Mozambican surgeons alone. The mean follow-up was 2.7±2.8 years
(1 month – 11 years). The mean age of patients was 15±6 years, with almost one
third of patients living at more than 1000km from the heart institute. Principal
indications of surgery was congenital heart disease in 47% (14.1% of ventricular
septal defect, 13.4% of tetralogies of Fallot, 5.8% of atrial septal defect, 5.3% of
ductus arteriosus and 7.4% of more complex congenital heart diseases), rheumatic
heart disease in 33%, endomycardial fibrosis in 8%. Mean hospital stay was
8 days±12 days. Peri-operative mortality rate was 5.9%, with significant difference
between indications: 6.6% for congenital heart diseases, 2.3% for RHD and 6.8%
for EMF (P=0.02). Among patients with mechanical prostheses, the mortality
associated with the prosthesis was high (18.3%). More than half of patients were
lost of follow-up at 3-year, and prevention of rheumatic heart disease non optimal
for many children…
Conclusion Our findings suggest the feasibility of such a program, with
development of local competences and finally the set-up of an independent
surgical team with effective intensive care unit. However, our results also
emphasize some weaknesses, especially the issue of follow-up of patients who
would benefited the most of long-term preventive measures.
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Aims Brugada Syndrome (BrS) is an arrhythmogenic disease associated
with sudden cardiac death (SCD) which seldom manifests and is recognized
in childhood. We aim to describe the pediatric BrS clinical presentation to
identify prognostic factors for risk stratification, and to propose a data-based
approach management.
Methods and results We studied 106 patients, under 19 years of age at diag-
nosis with spontaneous (n=36) or drug-induced (n=70) BrS from 16 European
hospitals. At diagnosis, mean age was 11.1±5.7 years and most patients were
asymptomatic [family screening (n=67), incidental (n=13)] while 15 had experi-
enced syncope, 6 aborted SCD or symptomatic ventricular tachycardia, 2 supra-
ventricular tachycardia (SVT), 3 palpitations or presyncope. During follow-up
(median: 54 months), 10 patients had life-threatening arrhythmias (LTA) including
3 deaths. Six experienced syncope and 4 SVT. Fever triggered 27% of LTA
events. An ICD was implanted in 22 with major adverse events in 41%. Of the 11
patients treated with hydroquinidine, 8 remained asymptomatic. Genetic testing
was performed in 75 patients and SCN5A rare variants were identified in 58;
among the 32 pediatric probands tested 15 were genotype positive. Of the
10 patients with LTA the 9 with genetic testing were all genotype positive whereas
the 17 SCN5A negative patients remained asymptomatic. Spontaneous BrS type
1 ECG (p=0.005) and symptoms at diagnosis (p=0.0015) were predictors of LTA.
Time to the first LTA event was shorter in patients with both symptoms at diag-
nosis and spontaneous BrS type 1 ECG pattern (p=0.01) (figure 1).
Conclusions Spontaneous type 1 ECG and symptoms at diagnosis are pre-
dictors of LTA events in the young affected by BrS. The management of BrS
should become age-specific and prevention of SCD may involve genetic
testing, aggressive use of anti-pyretics and quinidine with risk-specific consi-
deration for the ICD.
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Abstract C02 – Figure 1: Kaplan-Meier curves of LTA events
during follow-up in four different groups (global p-value =0.01).
